Search Results - "Basic Kinda, S."

PB2152: BIOLOGICAL AND CLINICAL CORRELATES OF GALECTIN‐3 (GAL‐3) EXPRESSION IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) by Basic‐Kinda, S., Ilic, I., Duletic‐Nacinovic, A., Jonjic, N., Radman, I., Valkovic, T., Serventi‐Seiwerth, R., Dujmovic, D., Dreta, B., Santek, F., Aurer, I.

Get full text

P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON‐HODGKIN'S LYMPHOMA DURING COVID‐19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES by Galusic, D., Basic ‐ Kinda, S., Pijuk, A., Milunovic, V., Dreta, B., Franjic, N., Coha, B., Sincic – Petricevic, J., Gacina, P., Pejsa, V., Lucijanic, M., Aurer, I.

Get full text

P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM by Aurer, I., Basic‐Kinda, S., Grubesic, A., Jaksic, O., Mrdenovic, S., Novakovic‐Coha, S., Lozic, D., Mikulic‐Pisk, M., Serventi‐Seiwerth, R., Dujmovic, D., Ostojic, A., Dreta, B., Pavlisa, G., Narancic, M., Hude‐Dragicevic, I., Valkovic, T.

Get full text

Polycythemia as the first manifestation of Cushing’s disease by Dusek, T., Kastelan, D., Solak, M., Basic Kinda, S., Aganovic, I., Korsic, M.

Get full text

PB2018: MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM RELAPSE IN THE ERA OF NOVEL DRUGS ‐ A MULTICENTER RETROSPECTIVE STUDY FROM THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL MALIGNANCIES (KROHEM) by Mitrovic, Z., Batinic, J., Radic Kristo, D., Krecak, I., Holik, H., Perisa, V., Valkovic, T., Matijaca, H., Pirsic, M., Basic Kinda, S., Aurer, I.

Get full text

Therapy-related acute myeloblastic leukemia after splenectomy in a patient with composite lymphoma developing after treatment of chronic lymphocytic leukemia by Valković, T., Seili-Bekafigo, I., Bašić-Kinda, S., Labar, B., Duletić-Načinović, A., Pećanić, S., Jonjić, N.

Get full text

Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study by Malinverni, Chiara, Bernardelli, Andrea, Glimelius, Ingrid, Mirandola, Massimo, Smedby, Karin E., Tisi, Maria Chiara, Giné, Eva, Albertsson-Lindblad, Alexandra, Marin-Niebla, Ana, Di Rocco, Alice, Moita, Filipa, Sciarra, Roberta, Bašić-Kinda, Sandra, Hess, Georg, Ohler, Anke, Eskelund, Christian W., Re, Alessandro, Ferrarini, Isacco, Kolstad, Arne, Räty, Riikka, Quaglia, Francesca Maria, Eyre, Toby A., Scapinello, Greta, Stefani, Piero Maria, Morello, Lucia, Nassi, Luca, Hohaus, Stefan, Ragaini, Simone, Zilioli, Vittorio Ruggero, Bruna, Riccardo, Cocito, Federica, Arcari, Annalisa, Jerkeman, Mats, Visco, Carlo

“…•Patients with MCL experiencing late relapse benefit from BTK-inhibitors over chemoimmunotherapies.•Overall, chemoimmunotherapies as second-line treatment are…”
Get full text

Outcomes of younger patients with mantle‐cell lymphoma experiencing late relapse (>24 months): the LATE‐POD study by Visco, C., Malinverni, C., Florea, E., Glimelius, I., Mirandola, M., Ekström‐Smedby, K., Tisi, M. C., Giné, E., Albertsson‐Lindblad, A., Niebla, A. Marin, Di Rocco, A., Moita, F., Sciarra, R., Bašić‐Kinda, S., Hess, G., Ohler, A., Eskelund, C., Re, A., Ferrarini, I., Kolstad, A., Räty, R., Quaglia, F. M., Bernardelli, A., Eyre, T. A., Scapinello, G., Stefani, P. M., Morello, L., Nassi, L., Hohaus, S., Ragaini, S., Zilioli, V. R., Bruna, R., Cocito, F., Arcari, A., Jerkeman, M.

Get full text

PO-0910: Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients by Bilic, L. Galunic, Santek, F., Soce, M., Grah, J.J., Kinda, S. Basic, Radman, I., Mitrović, Z., Martinović, M., Aurer, I.

Get full text

PB1963 CHARACTERISTICS OF NEWLY DIAGNOSED AUTOIMMUNE HEMOLYTIC ANEMIA: 5‐YEARS OF SINGLE‐CENTER EXPERIENCE by Pulanic, D., Raos, M., Vinkovic, M., Kilic, P., Rankovic, E., Samardzic, A., Vodanovic, M., Boban, A., Basic Kinda, S., Dujmovic, D., Roncevic, P., Batinic, J., Ostojic, A., Desnica, L., Radman, I., Zupancic Salek, S., Vrhovac, R., Golubic Cepulic, B., Aurer, I.

“…Background: Autoimmune hemolytic anemia (AIHA) is a rare autoimmune disease in which red blood cells (RBC) are targeted by autoantibodies confirmed with…”
Get full text

P124 The prevalence of JAK2 V617F mutation in myelodysplastic syndrome by Radič Antolic, M, Zadro, R, Rončevič, P, Bašič Kinda, S, Labar, B

Get full text

P075 Secondary malignancies after Hodgkin's disease by Bašić-Kinda, S, Boban, A, Radman, I, Petricevic, B, Labar, B

Get full text

P035 JAK2 V617F mutation and the clinical features in myeloproliferative disorders by Radić Antolic, M, Boban, A, Zadro, R, Juričević, M, Sučić, M, Bašić-Kinda, S, Labar, B

Get full text

P051 Immunohistochemical expression patterns of germinal center and activation B-cell markers do not correlate with prognosis in diffuse large B-cell lymphoma treated with R-CHOP by Mitrovic, Z, Aurer, I, Nola, M, Radman, I, Bašić-Kinda, S, Ajduković, R, Dominis, M, Labar, B

Get full text

P019 JAK2 V617F and FLT3 ITD mutation in myelodysplastic syndrome by Radić Antolic, M, Zadro, R, Rončević, P, Mrsić-Davidović, S, Franić-Šimić, I, Bašić-Kinda, S, Labar, B

Get full text

P078 Aggressive T-anaplastic large cell non-Hodgkin lymphoma in patient with chromosome breakage syndrome - a case report by Kinda Bašić, S, Radman, I, Pulanić, D, Lasan-Trčić, R, Kardum, I, Zupančić-Šalek, S, Aurer, I, Ilić, I, Labar, B

Get full text

Int J Hematol.: Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab by Dotlic, S, Ilic, I, Ajdukovic, R, Labar, B, Nola, M, Aurer, I, Radman, I, Basic-Kinda, S, Mitrovic, Z

Get full text

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 by Visco, C, Malinverni, C, Florea, E, Glimelius, I, Mirandola, M, Ekström-Smedby, K, Tisi, M C, Giné, E, Albertsson-Lindblad, A, Niebla, A Marin, Di Rocco, A, Moita, F, Sciarra, R, Bašić-Kinda, S, Hess, G, Ohler, A, Eskelund, C, Re, A, Ferrarini, I, Kolstad, A, Räty, R, Quaglia, F M, Bernardelli, A, Eyre, T A, Scapinello, G, Stefani, P M, Morello, L, Nassi, L, Hohaus, S, Ragaini, S, Zilioli, V R, Bruna, R, Cocito, F, Arcari, A, Jerkeman, M

Get full text

PB2204 SERUM YKL‐40 LEVELS ARE ELEVATED IN PRIMARY AND SECONDARY MYELOFIBROSIS AND MAY BE AFFECTING THEIR SURVIVAL by Krečak, I., Gverić‐Krečak, V., Rončević, P., Lapić, I., Fumic, K., Bašić‐Kinda, S., Duraković, N.

“…Background: Primary and secondary myelofibrosis (PMF and SMF) are clonal hematopoietic stem cell disorders characterized by myeloproliferation, bone marrow…”
Get full text

PB2327 SUBSTITUTING CARMUSTINE WITH BENDAMUSTINE IN BEAM RESULTS IN DELAYED PLATELET RECOVERY AND LESS MUCOSITIS WITH SIMILAR EFFICACY – A MATCHED PAIR ANALYSIS by Aurer, I., Zekanovic, I., Durakovic, N., Batinic, J., Dreta, B., Bašić‐Kinda, S., Sertić, D., Roncevic, P., Radman, I., Rincic, G., Bojanic, I., Periša, V., Lozic, D., Petrovic, J., Valkovic, T.

“…Background: Due to availability and pricing problems recently many transplant centers substituted carmustine in the BEAM regimen (carmustine, etoposide,…”
Get full text